By conducting a cross-dataset analysis of publicly available Gene Expression Omnibus (GEO) repositories, followed by functional validation in vitro and comprehensive metabolic profiling, we demonstrate that PIK3C2B drives tumor progression by enhancing EMT and mitochondrial bioenergetic flexibility. This evidence concerns the gene PIK3C2B and neoplasm.